Isodiol International Inc (ISOLF)
0.00
USD |
OTCM |
Apr 16, 16:00
Isodiol International Cash from Operations (TTM): 6.304M for Dec. 31, 2019
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2019 | 6.304M |
| September 30, 2019 | -0.3359M |
| June 30, 2019 | -2.280M |
| March 31, 2019 | -18.31M |
| December 31, 2018 | -35.34M |
| September 30, 2018 | -31.11M |
| June 30, 2018 | -28.18M |
| March 31, 2018 | -18.33M |
| December 31, 2017 | -6.375M |
| September 30, 2017 | -4.970M |
| Date | Value |
|---|---|
| June 30, 2017 | -3.958M |
| March 31, 2017 | -2.159M |
| December 31, 2016 | -1.919M |
| September 30, 2016 | -1.454M |
| June 30, 2016 | -1.234M |
| March 31, 2016 | -1.164M |
| December 31, 2015 | -0.6949M |
| September 30, 2015 | -0.2511M |
| June 30, 2015 | -0.401M |
| March 31, 2015 | -0.2715M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-2.280M
Minimum
Jun 2019
6.304M
Maximum
Dec 2019
1.230M
Average
-0.3359M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Liminal Biosciences Inc (DELISTED) | -27.11M |